FDA Import Refusal AEK-8314483-0/61/1 — Cipla Ltd.
The FDA refused shipment AEK-8314483-0/61/1 from Cipla Ltd. (India) on Mar 26, 2025. The refused product falls under Drugs and Biologics — BUDESONIDE (ANTI-ASTHMATIC). Cited charges: 118,75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Mar 26, 2025
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61ECE04 BUDESONIDE (ANTI-ASTHMATIC)
- Charges
- 118,75